Search Results - "Adrian V Hernandez"

Refine Results
  1. 1

    Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis by Zhang, Hua, Han, Han, He, Tianhui, Labbe, Kristen E, Hernandez, Adrian V, Chen, Haiquan, Velcheti, Vamsidhar, Stebbing, Justin, Wong, Kwok-Kin

    “…Abstract Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients with cancer have a high fatality rate. Methods We conducted a…”
    Get full text
    Journal Article
  2. 2

    Durability of branches in branched and fenestrated endografts by Mastracci, Tara M., MD, Greenberg, Roy K., MD, Eagleton, Matthew J., MD, Hernandez, Adrian V., PhD

    Published in Journal of vascular surgery (01-04-2013)
    “…Objective Branched and fenestrated repair has been shown to be effective for treatment of complex aortic aneurysms. However, the long-term durability of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Community-associated Clostridium difficile infection and antibiotics: a meta-analysis by Deshpande, Abhishek, Pasupuleti, Vinay, Thota, Priyaleela, Pant, Chaitanya, Rolston, David D K, Sferra, Thomas J, Hernandez, Adrian V, Donskey, Curtis J

    Published in Journal of antimicrobial chemotherapy (01-09-2013)
    “…Antibiotic exposure is the most important risk factor for Clostridium difficile infection (CDI). Most evaluations of antimicrobial risk factors have been…”
    Get full text
    Journal Article
  5. 5

    Brain Injury and Neurologic Outcome in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis by Migdady, Ibrahim, Rice, Cory, Deshpande, Abhishek, Hernandez, Adrian V, Price, Carrie, Whitman, Glenn J, Geocadin, Romergryko G, Cho, Sung-Min

    Published in Critical care medicine (01-07-2020)
    “…OBJECTIVES:Extracorporeal cardiopulmonary resuscitation has shown survival benefit in select patients with refractory cardiac arrest but there is insufficient…”
    Get full text
    Journal Article
  6. 6

    Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis by Deshpande, Abhishek, Pasupuleti, Vinay, Thota, Priyaleela, Pant, Chaitanya, Rolston, David D K, Hernandez, Adrian V, Donskey, Curtis J, Fraser, Thomas G

    “…An estimated 20-30% of patients with primary Clostridium difficile infection (CDI) develop recurrent CDI (rCDI) within 2 weeks of completion of therapy. While…”
    Get full text
    Journal Article
  7. 7

    Efficacy of psychological interventions on clinical outcomes of coronary artery disease: Systematic review and meta-analysis by Magán, Inés, Jurado-Barba, Rosa, Casado, Laura, Barnum, Haley, Jeon, Anne, Hernandez, Adrian V., Bueno, Héctor

    Published in Journal of psychosomatic research (01-02-2022)
    “…Psychological factors influence clinical outcomes in patients with coronary artery disease (CAD). Therefore, psychological interventions (PIs) may have…”
    Get full text
    Journal Article
  8. 8

    Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials by Malhotra, Konark, Chang, Jason J., Khunger, Arjun, Blacker, David, Switzer, Jeffrey A., Goyal, Nitin, Hernandez, Adrian V., Pasupuleti, Vinay, Alexandrov, Andrei V., Tsivgoulis, Georgios

    Published in Journal of neurology (01-08-2018)
    “…Background Various randomized-controlled clinical trials (RCTs) have investigated the neuroprotective role of minocycline in acute ischemic stroke (AIS) or…”
    Get full text
    Journal Article
  9. 9

    Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis by Piscoya, Alejandro, Ng-Sueng, Luis F, Parra Del Riego, Angela, Cerna-Viacava, Renato, Pasupuleti, Vinay, Roman, Yuani M, Thota, Priyaleela, White, C Michael, Hernandez, Adrian V

    Published in PloS one (10-12-2020)
    “…Efficacy and safety of treatments for hospitalized COVID-19 are uncertain. We systematically reviewed efficacy and safety of remdesivir for the treatment of…”
    Get full text
    Journal Article
  10. 10

    Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis by Hernandez, Adrian V, Pasupuleti, Vinay, Benites-Zapata, Vicente A, Thota, Priyaleela, Deshpande, Abhishek, Perez-Lopez, Faustino R

    Published in European journal of cancer (1990) (01-12-2015)
    “…Abstract Aim It has been suggested that chronic hyperinsulinemia from insulin resistance is involved in the etiology of endometrial cancer (EC). We performed a…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients by Diaz-Arocutipa, Carlos, Melgar-Talavera, Beatriz, Alvarado-Yarasca, Ángel, Saravia-Bartra, María M., Cazorla, Pedro, Belzusarri, Iván, Hernandez, Adrian V.

    “…•The use of statins was associated with a lower risk of mortality in COVID-19 patients.•Only chronic use of statins was significantly associated with lower…”
    Get full text
    Journal Article
  13. 13

    Effect of rural-to-urban within-country migration on cardiovascular risk factors in low- and middle-income countries: a systematic review by Hernández, Adrián V, Pasupuleti, Vinay, Deshpande, Abhishek, Bernabé-Ortiz, Antonio, Miranda, J Jaime

    Published in Heart (British Cardiac Society) (01-02-2012)
    “…Limited information is available of effects of rural-to-urban within-country migration on cardiovascular (CV) risk factors in low- and middle- income countries…”
    Get more information
    Journal Article
  14. 14

    Association between insulin resistance and breast carcinoma: a systematic review and meta-analysis by Hernandez, Adrian V, Guarnizo, Mirella, Miranda, Yony, Pasupuleti, Vinay, Deshpande, Abhishek, Paico, Socorro, Lenti, Hosten, Ganoza, Silvia, Montalvo, Laritza, Thota, Priyaleela, Lazaro, Herbert

    Published in PloS one (09-06-2014)
    “…This study was undertaken to evaluate the association between components defining insulin resistance and breast cancer in women. We conducted a systematic…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis by Deshpande, Abhishek, Pant, Chaitanya, Pasupuleti, Vinay, Rolston, David D.K, Jain, Anil, Deshpande, Narayan, Thota, Priyaleela, Sferra, Thomas J, Hernandez, Adrian V

    Published in Clinical gastroenterology and hepatology (01-03-2012)
    “…Background & Aims In the past decade, there has been a growing epidemic of Clostridium difficile infection (CDI). During this time, use of proton pump…”
    Get full text
    Journal Article
  17. 17

    Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors by Miao, Benjamin, Hernandez, Adrian V, Alberts, Mark J, Mangiafico, Nicholas, Roman, Yuani M, Coleman, Craig I

    Published in Journal of the American Heart Association (21-01-2020)
    “…Background There is a paucity of contemporary data estimating the incidence of major adverse cardiovascular events (MACE) in patients with established…”
    Get full text
    Journal Article
  18. 18

    Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis by Cicero, Arrigo F. G, Fogacci, Federica, Hernandez, Adrian V, Banach, Maciej, Misra, Adya

    Published in PLoS medicine (16-07-2020)
    “…Background Bempedoic acid is a first-in-class lipid-lowering drug recommended by guidelines for the treatment of hypercholesterolemia. Our objective was to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis by Piscoya, Alejandro, Parra Del Riego, Angela, Cerna-Viacava, Renato, Rocco, Jonathon, Roman, Yuani M, Escobedo, Angel A, Pasupuleti, Vinay, White, C Michael, Hernandez, Adrian V

    Published in PloS one (03-06-2022)
    “…We systematically assessed benefits and harms of tocilizumab (TCZ), which is an antibody blocking IL-6 receptors, in hospitalized COVID-19 patients. Five…”
    Get full text
    Journal Article